Reducing Residual Vascular Risk in Patients with Atherogenic Dyslipidemia: Where do we go from here?
Clin Lipidology. 2010;5(6):811-826. A considerable part of post-statin lipid abnormalities associated with RvR appear to result from abnormal levels of triglyceride (TG)-rich lipoproteins, of their ...
Dyslipidemia should be treated earlier to reduce lifelong risk for prolonged exposure to atherogenic lipoproteins. (HealthDay News) — In a clinical practice guideline issued by the American College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results